Netris pancreatic cancer study doses first patient
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials
Read More
Tag: pancreatic
Positive results for Ipsen’s metastatic pancreatic cancer treatment
Onivyde regimen demonstrated statistically significant improvement in overall survival
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
